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SUMMARY. In the present study, a simple, rapid and precise liquid chromatographic method was devel-
oped and validated for the determination of ezetimibe in its dosage form. Ezetimibe was separated in a 100
x 4.6 mm i.d., C18 column, 3 μm particle size, Luna phenomenex, using a mobile phase composition of wa-
ter and acetonitrile (60:40 v/v). Column oven temperature was kept at 25 °C. The flow rate was 1.5
mL/min and the analyte monitored at 225 nm. The retention time of Ezetimibe was 8.47 min. The specifici-
ty of the method was determined by assessing interference from the placebo and by stress testing of the
drug (forced degradation).The developed method was validated in terms of linearity, accuracy, precision,
system suitability, limit of detection, limit of quantitation and solution stability. The proposed method was
also applied successfully to the pharmaceutical dosage form self emulsified drug delivery without any in-
terference by excipients.
